VGI’s Upcoming Phase 2 NAFLD-NASH study to incorporate ENDRA’s TAEUS technology to help drive trial efficiencies In September 2015 a Phase 1a clinical study with IVB001 met all primary endpoints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results